Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sidhu, J.
Right arrow Articles by Jenkins, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sidhu, J.
Right arrow Articles by Jenkins, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2003; 96: 949-950
© Association of Physicians 2003; all rights reserved.

Correspondence

Men are at increased risk of amiodarone-associated thyrotoxicosis in the UK

The first 10% of the full text of this article appears below.

Sir,

Amiodarone is associated with both thyrotoxicosis and hypothyroidism.1 Previous estimates of the frequency of thyroid problems in amiodarone users have been based on small numbers of patients or hospital clinic populations. They range from 1% to 23% for thyrotoxicosis and from 1% to 32% for hypothyroidism.2 Amiodarone-associated thyrotoxicosis (AAT) seems commoner in men.3,4 This could reflect a bias . . . [Full Text of this Article]

J. Sidhu and D. Jenkins

Worcestershire Royal Hospital Worcester UK e-mail: david.jenkins@worcsacute.wmids.nhs.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
K.-H. Yiu, M.-H. Jim, C.-W. Siu, C.-H. Lee, M. Yuen, M. Mok, Y.-F. Shea, K. Fan, H.-F. Tse, and W.-H. Chow
Amiodarone-Induced Thyrotoxicosis Is a Predictor of Adverse Cardiovascular Outcome
J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 109 - 114.
[Abstract] [Full Text] [PDF]